Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
47.25 CHF | 0.00% |
|
0.00% | 0.00% |
12/07 | DOCMORRIS : Hauck & Aufhauser reaffirms its Buy rating | ZD |
12/07 | DOCMORRIS : Deutsche Bank reiterates its Buy rating | ZD |
Chart calendar DocMorris AG
Upcoming events on DocMorris AG
Past events on DocMorris AG
11/07/2024 | Q2 2024 Sales and Revenue Release - Trading Update |
29/05/2024 | UBS Swiss Day |
14/05/2024 | UBS Pan European Small and Mid Cap Conference |
02/05/2024 08:30 pm | Annual General Meeting |
16/04/2024 10:27 am | Q1 2024 Sales and Revenue Release - Trading Update |
22/03/2024 | Roadshow - Octavian |
21/03/2024 03:30 pm | Q4 2023 Earnings Call |
21/03/2024 11:30 am | Q4 2023 Earnings Release |
28/02/2024 | UBS European Healthcare Conference |
28/02/2024 | UBS European Healthcare Conference |
26/02/2024 | Morgan Stanley European MedTech and Life Sciences Conference |
07/02/2024 | Roadshow |
07/02/2024 | Roadshow |
07/02/2024 | Montega Hamburg Investor Day |
26/01/2024 | Roadshow |
26/01/2024 | Roadshow - Stifel - Day 2 |
25/01/2024 | Roadshow - Stifel - Day 1 |
25/01/2024 | Investor Meeting - Warburg- Klein aber fein |
25/01/2024 | Roadshow |
16/01/2024 11:30 am | Q4 2023 Sales and Revenue Release - Trading Update |
Past dividends on DocMorris AG
13/06/2016 | Other Dividend 0.5 CHF |
11/05/2015 | Annual 0.6 CHF |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 1 356 1 410 -3.88% | 1 477 1 583 -6.72% | 1 727 1 717 0.57% | 1 608 1 624 -0.96% | 967 972 -0.51% | 1 152 |
EBITDA Million CHF | Released Forecast Spread | -13,8 -9,78 -41.04% | -78,4 -38,7 -102.38% | -143 -136 -4.95% | -77,7 -74,5 -4.29% | -38,4 -42,7 10.09% | -24,4 |
EBIT Million CHF | Released Forecast Spread | -45,7 -36,8 -24.34% | -118 -72,3 -62.76% | -194 -182 -6.58% | -140 -127 -10.47% | -83,2 -86,9 4.3% | -67,1 |
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -50,1 -39,8 -25.76% | -133 -101 -31.96% | -227 -195 -16.27% | -170 -158 -7.51% | -119 -108 -9.7% | -89,4 |
Net income Million CHF | Released Forecast Spread | -52,4 -37,8 -38.74% | -136 -96,9 -40.01% | -226 -199 -13.41% | -171 -155 -10.09% | 82,2 -41,3 298.83% | -87,0 |
EPS CHF | Released Forecast Spread | -6,04 -4,40 -37.32% | -15,0 -9,91 -50.92% | -23,4 -18,9 -23.88% | -15,9 -13,5 -17.27% | 7,05 -4,86 245.06% | -7,09 |
Announcement Date | 19/03/20 | 18/03/21 | 24/03/22 | 24/03/23 | 20/03/24 | - |
Quarterly results
Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 687 689 -0.21% | 698 698 0.06% | 779 779 0% | 840 832 0.97% | 443 425 4.25% | 887 909 -2.41% | 419 426 -1.67% | 405 453 -10.56% | 824 906 -9.04% | 432 | 784 1 013 -22.58% | 403 432 -6.76% | 236 244 -3.29% | 463 459 0.98% | 249 | 268 | 504 487 3.58% | 265 | 283 | 546 | 649 |
EBITDA Million CHF | Released Forecast Spread | -11,3 -3,60 -215.11% | -24,5 -3,00 -715.13% | -53,9 -613 91.2% | -49,7 -47,5 -4.58% | -92,9 -81,0 -14.68% | -43,1 -59,0 26.95% | -34,6 -41,4 16.36% | -28,1 | -39,0 | 5,00 | |||||||||||
EBIT Million CHF | Released Forecast Spread | -73,1 -69,0 -5.96% | -121 -79,0 -52.77% | -69,5 -78,1 11.02% | -70,8 -56,0 -26.52% | -48,8 | -61,0 | -17,0 | ||||||||||||||
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -83,0 -73,0 -13.75% | -61,0 | -26,0 | ||||||||||||||||||
Net income Million CHF | Released Forecast Spread | -149 -130 -14.1% | -86,1 -90,0 4.35% | -61,0 | -26,0 | |||||||||||||||||
EPS CHF | Released Forecast Spread | -8,03 -7,53 -6.64% | -8,29 -9,36 11.43% | -7,59 -5,68 -33.63% | -5,17 | -2,20 | ||||||||||||||||
Announcement Date | 19/03/20 | 19/08/20 | 18/03/21 | 18/08/21 | 24/03/22 | 24/03/22 | 18/05/22 | 18/08/22 | 18/08/22 | - | 24/03/23 | 17/05/23 | 17/08/23 | 17/08/23 | - | - | 20/03/24 | - | - | - | - |
Past sector events for DocMorris AG
11/07/2024 | DOCMORRIS AG: Q2 2024 Sales and Revenue Release - Trading Update |
08/07/2024 | WELCIA HOLDINGS CO., LTD.: Q1 2024 Earnings Release |
04/07/2024 | WELCIA HOLDINGS CO., LTD.: Q1 2024 Earnings Release (Projected) |
27/06/2024 04:30 pm | WALGREENS BOOTS ALLIANCE, INC.: Q3 2024 Earnings Release |
20/06/2024 | SOPHARMA AD: May 2024 Sales and Revenue Release |
31/05/2024 10:35 am | DIS-CHEM PHARMACIES LIMITED: Q4 2024 Earnings Release |
30/05/2024 | SOPHARMA AD: Q1 2024 Earnings Release |
28/05/2024 04:21 pm | MEDPLUS HEALTH SERVICES LIMITED: Q4 2024 Earnings Release |
27/05/2024 | ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED: Q4 2024 Earnings Release |
20/05/2024 | SOPHARMA AD: April 2024 Sales and Revenue Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ROSE Stock
- ROSE Stock
- Calendar DocMorris AG